文献速递药物不良反应与药物警戒特殊人群用药

新生儿重症监护病房药物不良反应预测工具的开发与验证

Development and validation of a predictive tool for adverse drug reactions in neonates under intensive care.
PubMed 文献 · Br J Clin Pharmacol · 2023-11-28

本研究在巴西纳塔尔一家妇产医院的新生儿重症监护病房(NICU)开展巢式病例对照研究,纳入450名新生儿(150例病例和300例对照),开发并验证了一种预测NICU新生儿发生药物不良反应(ADR)的工具。工具包含5个独立危险因素,总分0-34分,分类截断点为≥15分;验证时受试者工作特征曲线下面积为0.74(95%CI 0.66-0.81),灵敏度52.02%(95%CI 47.40-56.64),特异度81.35%(95%CI 77.75-84.95)。结论认为该工具具有足够的区分能力,且使用了NICU中常规监测的变量。

要点

  • 工具包含5个独立ADR危险因素:当前机械通气、心率≥178次/分、静脉用药、处方药物≥5种、母亲妊娠期高血压。
  • 总分0-34分,分类截断点≥15分;验证时AUC为0.74(95%CI 0.66-0.81)。
  • 灵敏度52.02%(95%CI 47.40-56.64),特异度81.35%(95%CI 77.75-84.95)。

核心结论

  • 该工具在NICU新生儿中表现出足够的区分能力,可用于预测ADR风险。

研究设计与样本

  • 在巴西纳塔尔一家妇产医院NICU开展巢式病例对照研究,时间范围为2019年1月至2022年1月。
  • 共纳入450名新生儿,其中150例ADR病例和300例对照(每例病例随机配对2名对照)。
  • 使用2/3样本通过多变量logistic回归开发工具,采用Hosmer-Lemeshow检验评估校准,Brier分数评估性能,并通过bootstrap调整c统计量确定ROC曲线下面积进行验证。

主要发现

  • 识别出5个ADR独立危险因素:当前机械通气、心率≥178次/分、静脉用药、处方药物≥5种(以上为新生儿因素),以及母亲妊娠期高血压(母亲因素)。
  • 工具总分范围为0-34分,分类截断点为≥15分。
  • 验证时ROC曲线下面积为0.74(95%CI 0.66-0.81),灵敏度52.02%(95%CI 47.40-56.64),特异度81.35%(95%CI 77.75-84.95)。

关键数值与推荐

  • 工具总分0-34分,分类截断点≥15分。
  • 验证时AUC为0.74(95%CI 0.66-0.81),灵敏度52.02%(95%CI 47.40-56.64),特异度81.35%(95%CI 77.75-84.95)。

临床怎么用

  • 该工具使用NICU中常规监测的变量,可辅助临床药师识别ADR高风险新生儿。
  • 总分≥15分的新生儿可考虑为ADR高风险人群,需加强药学监护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Neonates hospitalized in neonatal intensive care units (NICUs) commonly experience adverse drug reactions (ADRs). Thus, we aimed to develop and validate a tool for predicting ADRs in neonates hospitalized in NICUs. METHODS: A nested case-control study in an open cohort with neonates admitted to the NICU of a maternity hospital in Natal, Brazil was conducted from January 2019 to January 2022 [Correction added on 4 December 2023, after first online publication: 2023 has been changed to 2019 in the preceding sentence.]. Neonates with ADR were randomly paired with 2 controls. For the development of the tool, a multivariate logistic regression was applied on 2/3 of the sample (cases with respective controls). The model's fit was evaluated using the Hosmer-Lemeshow test for calibration and the Brier score for performance assessment. Validation of the tool was performed by determining the area under the receiver operating characteristic curve with bootstrap adjusted c-statistics. RESULTS: In all, 450 neonates (150 cases and 300 controls) were included in the study. We identified 5 independent risk factors for ADR, 4 related to the neonate (current mechanical ventilation, heart rate ≥178 beats/min, intravenous medications, ≥5 prescription medications) and 1 to the mother (gestational hypertension). The tool had a classification cut-off point of ≥15, and its total score ranged from 0 to 34. In validation, the tool had an area under the receiver operating characteristic curve of 0.74 (95% confidence interval [CI] 0.66-0.81) with sensitivity of 52.02% (95% CI 47.40-56.64) and specificity of 81.35% (95% CI 77.75-84.95). CONCLUSION: The tool demonstrated adequate discriminative ability and utilized 5 commonly monitored variables in the NICU.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Leopoldino RW, Marques DP, Rocha LC, et al. Development and validation of a predictive tool for adverse drug reactions in neonates under intensive care. Br J Clin Pharmacol. 2023. PMID: 37926508. doi:10.1111/bcp.15954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。